The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.
Infection-related hospitalization is associated with incident heart failure, heart failure with preserved ejection fraction, and heart failure with reduced ejection fraction.
The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.
The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...